Publication | Closed Access

The sensitivity and specificity of the routine kidney biopsy immunofluorescence panel are inferior to diagnosing renal immunoglobulin-derived amyloidosis by mass spectrometry

UrologyMedicineRenal PathologyImmunologyDiagnosisBioanalysisPathologyMass SpectrometryRenal Immunoglobulin-derived AmyloidosisSerologic TestingBiomarker DiscoveryClinical ChemistryAntibody ScreeningChronic Kidney DiseaseNephrologyKidney Research